Skip to main content
. 2021 Apr 8;29(5):505–518. doi: 10.1038/s41417-021-00326-4

Fig. 1. Establishment of gene-edited KRAS-mutant pancreatic epithelial cells.

Fig. 1

a Schema of cell selection. Gene-edited cells generated by transient transfection with gRNA, Cas9 complex, and ssODN, were sequentially selected by limiting dilution and ddPCR, yielding gene-edited monoclonal cells, blue and red wells, wild-type and KRAS mutant cells, respectively. b Determination of the levels of mutant KRAS (G12V) (genome-edited in cKRAS and HA-tagged mutant KRAS expression in vKRAS) and of related intracellular signaling molecules by Western blotting. The vKRAS construct has an HA-tag and is a slightly heavier molecule. Representative results from three independent experiments are shown. Band intensities of phosphorylated ERK (p-ERK) and phosphorylated AKT (p-AKT) are indicated below the images. c Determination of RAS activity by ELISA. Results are the average of three biological replicates; error bars represent the SD. *p < 0.05; **p < 0.01. d Cell growth curve. Cell numbers relative to those at day 0 are indicated. Results are the average of three biological replicates; error bars represent SD. **p < 0.01.